23 /100
LOW RISK
Score updated Jul 13, 2026

CTS — CTS Corporation Dilution Risk Tracker

Track CTS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CTS — Get alerts when the score changes →

As of July 13, 2026, CTS Corporation (CTS) has a DilutionWatch DilutionScore of 23/100, rated LOW dilution risk. CTS Corporation has a market capitalization of $1.84B, 28.59M shares outstanding, 244 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
38
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
40
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CTS.
🔔 Track CTS — Get forecast alerts →

💹 Market Data

Market Cap$1.84B
Shares Outstanding28.59M
Float27.97M
Cash$90.85M
Debt$75.00M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 7.0% shares (2026Q1 vs prior)
244 institutional holders · 30.28M shares
#1 BlackRock, Inc. 4.40M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 2.48M shares
#3 WASATCH ADVISORS LP 1.99M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest1.10M
Days to Cover2.2
% of Float3.9%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

4 INSIDER TRANSACTION Feb 26, 2026
4 INSIDER TRANSACTION Feb 26, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for CTS Shareholders

CTS Corporation (CTS) has a DilutionScore of 23/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for CTS shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for CTS in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for CTS alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track CTS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CTS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

LBTYA LBTYK AER AIG BABA

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for CTS
📊 CTS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CTS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.